IgG4-Related Disease: Results From a Multicenter Spanish Registry

Published on Aug 1, 2015in Medicine1.552
· DOI :10.1097/MD.0000000000001275
Andreu Fernández-Codina10
Estimated H-index: 10
,
Fernando Martínez-Valle9
Estimated H-index: 9
+ 18 AuthorsGonzalo Salvador-Cervelló1
Estimated H-index: 1
Sources
Abstract
IgG4-related disease (IgG4-RD) is a rare entity consisting of inflammation and fibrosis that has been described in multiple organs. Concrete diagnostic criteria have been established recently and there is a lack of large series of patients. To describe the clinical presentation, histopathological characteristics, treatment and evolution of a series of IgG4-RD Spanish patients. A retrospective multicenter study was performed. Twelve hospitals across Spain included patients meeting the current 2012 consensus criteria on IgG4-RD diagnosis. Fifty-five patients were included in the study, 38 of whom (69.1%) were male. Median age at diagnosis was 53 years. Thirty (54.5%) patients were included in the Histologically Highly Suggestive IgG4-RD group and 25 (45.5%) in the probable IgG4-RD group. Twenty-six (47.3%) patients had more than 1 organ affected at presentation. The most frequently affected organs were: retroperitoneum, orbital pseudotumor, pancreas, salivary and lachrymal glands, and maxillary sinuses. Corticosteroids were the mainstay of treatment (46 patients, 83.6%). Eighteen patients (32.7%) required additional immunosuppressive agents. Twenty-four (43.6%) patients achieved a complete response and 26 (43.7%) presented a partial response (<50% of regression) after 22 months of follow-up. No deaths were attributed directly to IgG4-RD and malignancy was infrequent. This is the largest IgG4-RD series reported in Europe. Patients were middle-aged males, with histologically probable IgG4-RD. The systemic form of the disease was frequent, involving mainly sites of the head and abdomen. Corticosteroids were an effective first line treatment, sometimes combined with immunosuppressive agents. Neither fatalities nor malignancies were attributed to IgG4-RD.
📖 Papers frequently viewed together
20151.55Medicine
13 Authors (Dai Inoue, ..., Yoh Zen)
204 Citations
1,443 Citations
445 Citations
References24
Newest
#1Yasuhiro MaedaH-Index: 17
#2Shunya NakaneH-Index: 17
Last. Hidenori MatsuoH-Index: 21
view all 15 authors...
AbstractObjectives: Autonomic dysfunction is closely associated with autoimmune diseases (AID) including primary biliary cirrhosis (PBC). The objective of this study was to determine the prevalence of anti-ganglionic (nicotinic) acetylcholine receptor (gAChR) antibodies in patients with AID.Methods: We determined the presence of gAChR antibodies in serum samples from 146 patients (systemic lupus erythematosus [SLE] = 32; rheumatoid arthritis [RA] = 43; systemic sclerosis [SSc] = 38; PBC= 33) wit...
24 CitationsSource
#1Motohisa Yamamoto (Sapporo Medical University)H-Index: 40
#2Hidetaka Yajima (Sapporo Medical University)H-Index: 12
Last. Yasuhisa Shinomura (Sapporo Medical University)H-Index: 82
view all 21 authors...
AbstractObjective. Immunoglobulin (Ig)G4-related disease (IgG4-RD) is a new disease entity that has only been identified this century. Clinical information is thus lacking. We established the Sapporo Medical University and Related Institutes Database for Investigation and Best Treatments of IgG4-related Disease (SMART) to clarify the clinical features of IgG4-RD and provide useful information for clinicians.Methods. Participants comprised 122 patients with IgG4-related dacryoadenitis and/or sial...
69 CitationsSource
#1Mollie N. Carruthers (Harvard University)H-Index: 15
#2Arezou Khosroshahi (Emory University)H-Index: 31
Last. John H. Stone (Harvard University)H-Index: 94
view all 5 authors...
Objectives We evaluated the sensitivity, specificity and positive and negative predictive values of elevated serum IgG4 concentrations for the diagnosis of IgG4-RD. Methods Between 2001 and 2011, 190 unique patients had elevated serum IgG4 measurements. We reviewed electronic medical records to determine the indication for IgG4 measurement and underlying clinical diagnosis. Additionally, we reviewed the records of 190 other randomly selected patients from a pool of 3360 with normal results, to e...
257 CitationsSource
#1Zachary S. Wallace (Harvard University)H-Index: 27
#2Hamid Mattoo (Harvard University)H-Index: 23
Last. John H. Stone (Harvard University)H-Index: 94
view all 10 authors...
Objectives We examined the utility of circulating total and IgG4+ plasmablasts as biomarkers of diagnosis and disease activity in IgG4-related disease (IgG4-RD). Materials methods We evaluated patients with active, untreated, biopsy-proven IgG4-RD affecting various organs. Flow cytometry was used to measure total plasmablast and IgG4+ plasmablast counts by gating peripheral blood for CD19lowCD38+CD20−CD27+ cells and CD19lowCD38+CD20−CD27+IgG4+ cells. Serum IgG4 concentrations were measured by ne...
278 CitationsSource
#1Pilar Brito-ZerónH-Index: 51
#2Manuel Ramos-CasalsH-Index: 90
Last. John H. Stone (Harvard University)H-Index: 94
view all 4 authors...
Abstract IgG4-related disease (IgG4-RD) is an emerging immune-mediated disease with the capability of involving essentially any organ. The epidemiology of this disease has not been explored in detail. A majority of patients reported in the literature to date are from Japan, but the condition has been described all across the world and there is no strong evidence to suggest a predilection for Asian populations. The mean age at diagnosis is approximately 60 years and there is a decided male predom...
165 CitationsSource
#1Hisanori Umehara (Kanazawa Medical University)H-Index: 56
#2Akio Nakajima (Kanazawa Medical University)H-Index: 12
Last. Mitsuhiro Kawano (Kanazawa University)H-Index: 34
view all 7 authors...
IgG4-related disease (IgG4-RD) is a novel clinical entity proposed in Japan in the 21th century and is attracting strong attention over the world. The characteristic manifestations of IgG4-RD are increased serum IgG4 concentration and tumefaction by IgG4+ plasma cells. Although the clinical manifestations in various organs have been established, the pathogenesis of IgG4-RD is still unknown. Recently, many reports of aberrant acquired immunity such as Th2-diminated immune responses have been publ...
47 CitationsSource
#1Andreu Fernández-Codina (Autonomous University of Barcelona)H-Index: 10
#2Fernando Martínez-Valle (Autonomous University of Barcelona)H-Index: 9
Last. José Ordi-Ros (Autonomous University of Barcelona)H-Index: 9
view all 6 authors...
6 CitationsSource
#1Kenji Hirano (UTokyo: University of Tokyo)H-Index: 46
#2Minoru Tada (UTokyo: University of Tokyo)H-Index: 60
Last. Kazuhiko Koike (UTokyo: University of Tokyo)H-Index: 92
view all 27 authors...
OBJECTIVE: It has been discussed whether IgG4-related disease (IgG4-RD), including autoimmune pancreatitis (AIP), is associated with malignancy; however, the issue has not been clarified. METHODS: We analyzed 113 patients with IgG4-RD in whom malignancy was not diagnosed at the time of IgG4-RD onset and the follow-up period was longer than six months. A total of 95 patients had AIP. The mean follow-up period was 73 months. The incidence of the observed malignancies was compared with the expected...
78 CitationsSource
#1Phil A. Hart (Mayo Clinic)H-Index: 28
#2Mark Topazian (Mayo Clinic)H-Index: 65
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 14 authors...
Background There is a paucity of data on long-term management of type 1 autoimmune pancreatitis (AIP), a relapsing steroid-responsive disorder. Objective We describe our experience with treatment of relapses and maintenance of remission using steroid-sparing immunomodulators (IMs) and induction of remission using rituximab (RTX). Methods We obtained details of disease relapse and treatment in 116 type 1 AIP patients from clinic visits, medical records and telephone interviews. We compared relaps...
235 CitationsSource
Idiopathic retroperitoneal fibrosis (IRF) is a rare disease, characterised by a fibroinflammatory tissue surrounding the aortoiliac axis and frequently entrapping the ureters.1 ,2 Glucocorticoids effectively induce remission, but 24% to 72% of patients relapse, half of them repeatedly.3 ,4 Immunosuppressants and glucocorticoids are usually required in relapsing IRF but no studies are available. In this prospective, open-label trial we enrolled 16 relapsing patients with IRF (July 2004 to April 2...
31 CitationsSource
Cited By70
Newest
Source
#2A. Pérez GómezH-Index: 5
Last. M. Álvarez-Mon SotoH-Index: 3
view all 4 authors...
Source
#1Yueying Pan (HUST: Huazhong University of Science and Technology)H-Index: 4
#2Shuchang Zhou (HUST: Huazhong University of Science and Technology)H-Index: 5
Last. Hanxiong Guan (HUST: Huazhong University of Science and Technology)H-Index: 4
view all 6 authors...
The features and treatment of 98 Chinese patients with immunoglobulin G4 (IgG4)-related disease (IgG4-RD) referred to a single tertiary referring centre were reviewed. Patients diagnosed with IgG4-RD according to the comprehensive diagnostic criteria (CDC) were included in the retrospective study from May 2012 to March 2019. We collected data on clinical, laboratory, imaging, histological features and treatment. Totally, 98 patients with IgG4-RD were enrolled. The common clinical manifestations ...
Source
#1Marco Lanzillotta (UniSR: Vita-Salute San Raffaele University)H-Index: 16
#2Andreu Fernández-Codina (UWO: University of Western Ontario)H-Index: 10
Last. Emanuel Della-Torre (UniSR: Vita-Salute San Raffaele University)H-Index: 27
view all 7 authors...
INTRODUCTION Awareness of IgG4-related disease (IgG4-RD) is increasing worldwide and specialists are now familiar with most of its clinical manifestations and mimickers. IgG4-RD promptly responds to glucocorticoids and repeated courses are typically used to induce and maintain remission because the disease relapses in most patients. If left untreated it can lead to organ dysfunction, organ failure and death. Advancement in our understanding of IgG4-RD pathogenesis is leading to the identificatio...
Source
Resumen La enfermedad relacionada con IgG4 (ER-IgG4) es una enfermedad sistemica reconocida. Se describio tras observarse que pacientes diagnosticados de pancreatitis autoinmune mostraban signos de enfermedad extrapancreatica. La clinica de estos pacientes es subaguda y se manifiesta por aparicion de lesiones seudotumorales, o tumores inflamatorios o fibrosos. En ocasiones, puede ser grave, como en el caso de pacientes con colangitis o vasculitis de gran vaso. Los criterios diagnosticos incluyen...
Source
Resumen La enfermedad relacionada con IgG4 (ER-IgG4) es una enfermedad sistemica reconocida. Se describio tras observarse que pacientes diagnosticados de pancreatitis autoinmune mostraban signos de enfermedad extrapancreatica. La clinica de estos pacientes es subaguda y se manifiesta por aparicion de lesiones seudotumorales, o tumores inflamatorios o fibrosos. En ocasiones, puede ser grave, como en el caso de pacientes con colangitis o vasculitis de gran vaso. Los criterios diagnosticos incluyen...
Source
#1Yanying Liu (PKU: Peking University)H-Index: 13
#2Lijuan Zhu (Zhengzhou University)H-Index: 1
Last. Zhanguo Li (PKU: Peking University)H-Index: 35
view all 16 authors...
Objectives IgG4-related disease (IgG4-RD) is recently recognized as a fibro-inflammatory condition featured by tumefactive lesions in multiple organs, and the retroperitoneum is one of the common involved sites. We undertook this study to compare detailed demographic, clinical and laboratory characteristics of IgG4-RD patients with retroperitoneum lesion (IgG4-RD RPF+) and retroperitoneum free IgG4-RD (IgG4-RD RPF-) in a large cohort. Methods We carried out a retrospective review of the medical ...
Source
#1K. Sakata (Keio: Keio University)H-Index: 2
#2Jun Kikuchi (Keio: Keio University)H-Index: 5
Last. Tsutomu Takeuchi (Keio: Keio University)H-Index: 84
view all 11 authors...
We herein report a rare case of a 66-year-old man with refractory chylothorax. Although he had been treated with moderate doses of prednisolone (PSL) on suspicion of pleuritis with Sjogren syndrome, the pleural effusion expanded after the reduction of prednisolone. Further workup including histopathological examinations of pleura led to the diagnosis of IgG4-RD with bilateral chylothorax without any leakage from the thoracic duct. Combination therapy with high-dose PSL plus rituximab successfull...
Source
#1Annarosa Floreani (UNIPD: University of Padua)H-Index: 58
#2Kazuichi Okazaki (Kansai Medical University)H-Index: 83
Last. M. Eric Gershwin (UC Davis: University of California, Davis)H-Index: 137
view all 4 authors...
IgG4-related disease (IgG4-RD) represents an immune-mediated fibroinflammatory condition with peculiar histopathologic changes that can affect various organs. In 2012 its unified nomenclature was published, which allows to abandon other synonymous names. Up to now, only little is known about its epidemiology around the world. However, although it is generally considered a rare condition, the number of patients with IgG4-RD is increasing enormously. Likewise, the annual number of publications on ...
Source
#1Haruna Arai (Fujita Health University)H-Index: 2
#2Soshiro Ogata (Fujita Health University)H-Index: 3
Last. Hiroki Hayashi (Fujita Health University)H-Index: 12
view all 10 authors...
The present study aimed to investigate associations between long-term renal function, whether IgG4-related tubulointerstitial nephritis (TIN) was diagnosed by renal biopsy at initial examination, chronic kidney disease (CKD) stage, and histological stage in patients with IgG4-related TIN. This study used a retrospective cohort design including almost all patients who underwent renal biopsy at Fujita Health University Hospital and Nagoya University or its affiliated hospitals in Aichi between Apr...
2 CitationsSource